Press Releases
International Women’s Day: Aude CARLIER, Algenics’ CEO, invited to the Elysée Presidential palace
Saint-Herblain (FRANCE) – March 08, 2013 - Aude CARLIER, CEO and co-founder of Algenics, has been honored to be invited to the Elysée Presidential palace for the International Women’s Day on Friday, March 8th. Together with Ms Najat VALLAUD-BELKACEM, Minister of … Continue reading
ALGENICS receives grant to support development of its microalgal protein expression technology for the production of monoclonal antibodies in oncology
Saint-Herblain (FRANCE) – January 30, 2012 – Algenics, the biopharmaceutical company offering a unique microalgae-based solution for the development of recombinant biotherapeutics, announced that it has received a grant from OSEO, the French innovation agency, with the support of the … Continue reading
ALGENICS announces €150 000 Participative Priming Loan from OSEO
Saint-Herblain (FRANCE) – September 22, 2011 – Algenics, the biopharmaceutical company offering a unique microalgae-based solution for the development of recombinant biotherapeutics, announced that it has obtained a €150 000 Participative Priming Loan (“Prêt Participatif d’Amorçage”) granted by OSEO, the … Continue reading
ALGENICS and NOVIMMUNE announce a research collaboration to express fully human antibodies using the microalgal PTA cell line
Saint-Herblain (France) Plan-les-Ouates (Switzerland) – June 17, 2011. Algenics announced a new research collaboration with NovImmune to biomanufacture monoclonal therapeutic antibodies using its proprietary expression platform AlgebiosysTM. Two fully human therapeutic antibodies have been retained from NovImmune’s current pipeline to … Continue reading